“Here the safety follow-up is longer. So, what we have done is that we have presented interim data. The trial design is such that one month...

Bharat Biotech has completed the Phase 2/3 trials of COVID-19 vaccine Covaxin for use in children under 18 years of age.

Its pricing will be decided at a meeting between company representatives and the National Expert Group in Vaccine Administration for Covid ...

The country’s top paediatricians will review international data on children vaccinated against Covid-19 and present it to the National Tech...

Children over the age of 12 with underlying medical conditions are likely to be vaccinated first, while healthy kids are unlikely to get ja...

"The screening of children for conducting trial of Covaxin has started. Participants would be given the vaccine after their screening repor...

The US and Canada have started vaccinating those above age 12 years, as the Pfizer and Moderna vaccines in use in those countries have rece...

Covid-19 vaccination could arguably be the most challenging exercise India has embarked upon. How will the government roll it out? What mak...

The big ‘but’ butts into scalability. The usual sticking point of lab-to-arm is hugely multiplied when dealing with a totally new vaccine a...

Even though the Centre had planned to extend swine flu testing and treatment facility to the private sector, the union health ministry clai...